+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ceritinib"

Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • November 2023
  • 630 Pages
  • Global
From
Global Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Global Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • November 2023
  • 306 Pages
  • Global
From
Global Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Global Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • July 2023
  • 290 Pages
  • Global
From
Anaplastic lymphoma kinase Non-Small Cell Lung Cancer (ALK-NSCLC) - Market Insight, Epidemiology and Market Forecast -2032 - Product Thumbnail Image

Anaplastic lymphoma kinase Non-Small Cell Lung Cancer (ALK-NSCLC) - Market Insight, Epidemiology and Market Forecast -2032

  • Report
  • January 2022
  • 200 Pages
  • Global
From
Lorlatinib - Product Thumbnail Image

Lorlatinib

  • Report
  • August 2018
  • 16 Pages
  • Global
From
Zykadia - Product Thumbnail Image

Zykadia

  • Report
  • August 2018
  • 19 Pages
  • Global
From
Global and Chinese Ceritinib Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Ceritinib Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 135 Pages
  • China, Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Ceritinib is an oncology drug used to treat non-small cell lung cancer (NSCLC). It is a type of tyrosine kinase inhibitor (TKI) that works by blocking the activity of certain proteins that are involved in the growth and spread of cancer cells. Ceritinib is approved for the treatment of metastatic NSCLC in patients whose tumors have a specific genetic mutation known as ALK-positive. It is also approved for the treatment of NSCLC in patients who have progressed after treatment with crizotinib, another TKI. Ceritinib is available in tablet form and is taken orally once daily. Common side effects include nausea, vomiting, diarrhea, fatigue, and decreased appetite. More serious side effects may include liver damage, heart problems, and lung inflammation. Ceritinib is marketed by Novartis, Daiichi Sankyo, and Eisai. Show Less Read more